are all tirzepatide compounds the same What Is Compounded & Is It Right Solution for You? Compounded Tirzepatide to Treat Diabetes

What makes SOBOBA Medical Weight Loss program unique

Your PlexusDx provider can recommend the most appropriate reflux management strategy based on your symptom severity and medical history

Active Ingredient : Semaglutide, a GLP-1 receptor agonist Mechanism of Action : According to FDA prescribing information, semaglutide works by: Increasing glucose-dependent insulin secretion Decreasing glucagon secretion Slowing gastric emptying Acting on centers in the brain that regulate appetite Clinical Trial Evidence - STEP Program : According to published data from the STEP 1 trial (New England Journal of Medicine, 2021): Study Design : 68-week randomized, double-blind, placebo-controlled trial 1,961 adults without diabetes Inclusion: BMI 30 or 27 with weight-related conditions Intervention: Once-weekly subcutaneous semaglutide 2.4 mg Lifestyle: 500-calorie deficit diet plus 150 minutes/week physical activity Primary Results : Semaglutide group: Average 14.9% body weight loss (approximately 33 lbs for 220 lb individual) Placebo group: Average 2.4% body weight loss (approximately 5 lbs for 220 lb individual) Difference: 12.4 percentage points (p 3 pounds/week associated with higher risk

Understanding your genetic context, combined with baseline biomarkers like fasting glucose, HbA1c, and lipid panels, can support a more personalized dosing conversation with your healthcare provider